Európska únia -
slovenčina -
EMA (European Medicines Agency)
circadin
rad neurim pharmaceuticals eec sarl - melatonín - poruchy spánku a poruchy obsluhy - psycholeptika - circadin je indikovaný ako monoterapia na krátkodobé liečenie primárnej nespavosti charakterizovanej nízkou kvalitou spánku u pacientov vo veku 55 rokov alebo starších.
Európska únia -
slovenčina -
EMA (European Medicines Agency)
ceplene
laboratoires delbert - histamín dihydrochloride - leukémia, myeloidná, akútna - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). Účinnosť lieku ceplene nebola úplne preukázaná u pacientov starších ako 60 rokov.
Slovensko -
slovenčina -
Ústav štátnej kontroly veterinárnych biopreparátov a liečiv
fipron 268 mg spot-on roztok pre psy l
bioveta, Česká republilka - sol.
Slovensko -
slovenčina -
Ústav štátnej kontroly veterinárnych biopreparátov a liečiv
tramvetol 50 mg tablety pre psy
virbac, francúzsko - tbl.
Európska únia -
slovenčina -
EMA (European Medicines Agency)
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - klopidogrel hydrochlorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotické činidlá - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
sunitinib pharmagen 50 mg
pharmagen cz s.r.o., Česká republika - sunitinib - 44 - cytostatica
Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
sunitinib pharmagen 25 mg
pharmagen cz s.r.o., Česká republika - sunitinib - 44 - cytostatica
Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
sunitinib pharmagen 12,5 mg
pharmagen cz s.r.o., Česká republika - sunitinib - 44 - cytostatica